Governance / Clinical-grade
Phase 1 / Pilot intake open
Channel 03 / VETA Data & API

Clinical reasoning as
structured infrastructure.

For animal-health pharma, diagnostics, insurance, telehealth, and researchers. Species-aware, evidence-tiered, audit-trailed — built for API consumption, not human reading.

StatusDesign-partner only / Phase 2
Enterprise rate$25K–500K / yr hypothesis
FirewallChannel 3 isolated from 1 & 2 outputs
Buyers

Building this in-house is uneconomical for any single vertical.

Animal-health pharma

Structured signals for veterinary indications and R&D evidence synthesis.

Diagnostics

Embed species-aware reasoning into result interpretation and ordering pathways.

Insurance

Risk modeling, claim triage, and member-facing benefit via co-branded VETAi.

Telehealth

A governed reasoning substrate behind asynchronous and synchronous consults.

v1 surface / illustrative

A small, opinionated API on top of a deep governance layer.

Endpoint shapes are illustrative for partner conversations. Production contracts are co-authored with design partners.

POST /v1/triage
Risk-class output for an intake payload (species, signalment, complaint).
POST /v1/dose-check
Deterministic dose-ceiling and route validation per active ingredient.
POST /v1/interactions
Drug-drug and drug-condition interaction screening from V-EviCore.
GET /v1/evidence/:id
Versioned evidence object with source, tier, last-reviewed, and lineage.
POST /v1/output-contract
Render a structured output contract for the requested audience and risk class.
Channel 3 firewall

Enterprise customers cannot see Channel 1 or 2 outputs. Ever.

The same firewall that lets pharma, insurers, and diagnostics build against VETA is the firewall that protects clinic and owner trust. Cross-channel governance is enforced at the schema level — not at the application layer.

Honest phase framing

Two design partners, not a sales page.

VETA Data & API is a Phase 2 product. We are selecting two design partners whose use cases harden the schema before broader availability. Direct line to the founder and clinical board.